acc42901 |
Peptidyl-prolyl cis-trans isomerase A-like 4A |
oxidation |
Met61 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42902 |
Peptidyl-prolyl cis-trans isomerase A-like 4F |
oxidation |
Met61 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42903 |
Peptidyl-prolyl cis-trans isomerase A-like 4D |
oxidation |
Met61 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42904 |
Peptidyl-prolyl cis-trans isomerase A-like 4C |
oxidation |
Met61 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42905 |
Peptidyl-prolyl cis-trans isomerase A-like 4H |
oxidation |
Met61 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42906 |
Small ribosomal subunit protein eS21 |
oxidation |
Met34 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42907 |
Small ribosomal subunit protein eS21 |
oxidation |
Met62 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42908 |
Eukaryotic translation initiation factor 5A-1 |
oxidation |
Met79 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42909 |
Eukaryotic translation initiation factor 5A-1-like |
oxidation |
Met79 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42910 |
Eukaryotic translation initiation factor 5A-2 |
oxidation |
Met79 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42911 |
Thymosin beta-10 |
oxidation |
Met7 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42912 |
Elongation factor 1-alpha 1 |
oxidation |
Met102 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42913 |
Putative elongation factor 1-alpha-like 3 |
oxidation |
Met102 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42914 |
Elongation factor 1-alpha 2 |
oxidation |
Met102 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42915 |
Tubulin beta-4B chain |
oxidation |
Met363 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42916 |
Tubulin beta-2B chain |
oxidation |
Met363 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42917 |
Tubulin beta-2A chain |
oxidation |
Met363 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42918 |
T-complex protein 1 subunit beta |
oxidation |
Met480 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42919 |
T-complex protein 1 subunit beta |
oxidation |
Met244 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42920 |
DNA-dependent protein kinase catalytic subunit |
oxidation |
Met3820 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Negative |
3.0 |
PXD051376
|
acc42921 |
Enhancer of rudimentary homolog |
oxidation |
Met29 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42922 |
Receptor expression-enhancing protein 5 |
oxidation |
Met152 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42923 |
Heterogeneous nuclear ribonucleoprotein U |
oxidation |
Met593 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Negative |
3.0 |
PXD051376
|
acc42924 |
Serine/arginine-rich splicing factor 2 |
oxidation |
Met13 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42925 |
"ATP-dependent 6-phosphofructokinase, platelet type" |
oxidation |
Met363 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42926 |
"ATP-dependent 6-phosphofructokinase, platelet type" |
oxidation |
Met425 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42927 |
Peptidyl-prolyl cis-trans isomerase FKBP4 |
oxidation |
Met440 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42928 |
Peptidyl-prolyl cis-trans isomerase FKBP4 |
oxidation |
Met20 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42929 |
Elongation factor 1-alpha 2 |
oxidation |
Met208 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42930 |
Elongation factor 1-alpha 2 |
oxidation |
Met404 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42931 |
Elongation factor 1-alpha 2 |
oxidation |
Met276 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42932 |
Proteasome activator complex subunit 1 |
oxidation |
Met160 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42933 |
ATP-dependent RNA helicase A |
oxidation |
Met35 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42934 |
ATP-dependent RNA helicase A |
oxidation |
Met1036 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42935 |
Transcription intermediary factor 1-beta |
oxidation |
Met423 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42936 |
Transcription intermediary factor 1-beta |
oxidation |
Met443 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42937 |
Ras GTPase-activating protein-binding protein 1 |
oxidation |
Met109 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42938 |
Ras GTPase-activating protein-binding protein 1 |
oxidation |
Met66 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42939 |
28 kDa heat- and acid-stable phosphoprotein |
oxidation |
Met174 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42940 |
Spliceosome RNA helicase DDX39B |
oxidation |
Met364 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42941 |
Heterogeneous nuclear ribonucleoprotein D0 |
oxidation |
Met215 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Negative |
3.0 |
PXD051376
|
acc42942 |
Ubiquitin-associated protein 2-like |
oxidation |
Met295 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42943 |
Caprin-1 |
oxidation |
Met54 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42944 |
Importin subunit beta-1 |
oxidation |
Met788 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42945 |
26S proteasome non-ATPase regulatory subunit 6 |
oxidation |
Met50 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42946 |
Plectin |
oxidation |
Met2929 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Negative |
3.0 |
PXD051376
|
acc42947 |
Inorganic pyrophosphatase |
oxidation |
Met243 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42948 |
Inorganic pyrophosphatase |
oxidation |
Met58 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Positive |
3.0 |
PXD051376
|
acc42949 |
"POU domain, class 4, transcription factor 3" |
oxidation |
Met2 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Negative |
3.0 |
PXD051376
|
acc42950 |
"POU domain, class 4, transcription factor 3" |
oxidation |
Met31 |
human |
Breast Cancer |
MCF7 |
Mn2L2 |
Negative |
3.0 |
PXD051376
|